Sonoma Pharmaceuticals, Inc. (SNOA) stock
SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.05 (-5.21%)
Close on Nov 17, 2026Market cap $3.99MP/E –Yield –
Sonoma Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Sonoma Pharmaceuticals's total assets was $18.11M at Jun 30, 2026. For fiscal 2026 it was $13.96M, up 1.9% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $25.46M in fiscal 2017.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $13.96M | +1.9% |
| FY2025 | Mar 31, 2025 | $13.69M | -7.1% |
| FY2024 | Mar 31, 2024 | $14.74M | -9.2% |
| FY2023 | Mar 31, 2023 | $16.23M | -13.9% |
| FY2022 | Mar 31, 2022 | $18.85M | +25.7% |
| FY2021 | Mar 31, 2021 | $14.99M | +2.9% |
| FY2020 | Mar 31, 2020 | $14.56M | +0.8% |
| FY2019 | Mar 31, 2019 | $14.45M | -24.8% |
| FY2018 | Mar 31, 2018 | $19.21M | -24.6% |
| FY2017 | Mar 31, 2017 | $25.46M | +84.4% |
| FY2016 | Mar 31, 2016 | $13.80M | -8.3% |
| FY2015 | Mar 31, 2015 | $15.05M | -27.6% |
| FY2014 | Mar 31, 2014 | $20.79M | +65.5% |
| FY2013 | Mar 31, 2013 | $12.57M | +60.3% |
| FY2012 | Mar 31, 2012 | $7.84M | -9.5% |
| FY2011 | Mar 31, 2011 | $8.66M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $18.11M | +24.1% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $13.96M | +1.9% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $13.62M | -0.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $13.86M | +1.2% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $14.59M | +6.7% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $13.69M | -7.1% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $13.67M | -6.5% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $13.69M | +0.4% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $13.67M | -14.0% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $14.74M | -9.2% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $14.62M | +5.0% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $13.64M | -8.9% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $15.89M | -7.4% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $16.23M | -13.9% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $13.93M | -28.0% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $14.96M | -24.5% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $17.16M | +21.5% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $18.85M | +25.7% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $19.35M | +6.1% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $19.83M | +9.3% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $14.12M | -21.9% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $14.99M | +2.9% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $18.23M | +10.5% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $18.15M | +12.4% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $18.08M | +6.9% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $14.56M | +0.8% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $16.50M | -3.2% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $16.15M | +12.5% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $16.92M | +1.7% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $14.45M | -24.8% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $17.05M | -7.1% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $14.35M | -28.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $16.63M | -25.8% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $19.21M | -24.6% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $18.36M | -33.3% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $20.15M | +118.1% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $22.42M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $25.46M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $27.51M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $9.24M | – |
See a number that looks wrong?